<?xml version='1.0' encoding='utf-8'?>
<document id="24681287"><sentence text="Impact of 17-alpha-hydroxyprogesterone caproate on cytochrome P450s in primary cultures of human hepatocytes."><entity charOffset="10-47" id="DDI-PubMed.24681287.s1.e0" text="17-alpha-hydroxyprogesterone caproate" /></sentence><sentence text="The aim of this study was to examine the effects of 17-alpha-hydroxyprogesterone caproate (17OHP-C) on the activity and expression of several common hepatic cytochrome P450 (CYP) enzymes"><entity charOffset="52-89" id="DDI-PubMed.24681287.s2.e0" text="17-alpha-hydroxyprogesterone caproate" /><entity charOffset="91-98" id="DDI-PubMed.24681287.s2.e1" text="17OHP-C" /><pair ddi="false" e1="DDI-PubMed.24681287.s2.e0" e2="DDI-PubMed.24681287.s2.e0" /><pair ddi="false" e1="DDI-PubMed.24681287.s2.e0" e2="DDI-PubMed.24681287.s2.e1" /></sentence><sentence text="" /><sentence text="Primary human hepatocytes were pretreated with vehicle or 17OHP-C (0"><entity charOffset="58-65" id="DDI-PubMed.24681287.s4.e0" text="17OHP-C" /></sentence><sentence text="1 and 1 μmol/L) for 72 hours, then incubated for 1 hour with a cocktail of CYP substrates" /><sentence text=" The activity of various CYP enzymes was determined by measuring the formation of the metabolites of specific CYP substrates, using liquid chromatography-tandem mass spectrometry" /><sentence text=" The messenger RNA expression of various CYP enzymes was determined by real-time polymerase chain reaction" /><sentence text="" /><sentence text="In primary cultures of human hepatocytes, 17OHP-C minimally altered the activity or messenger RNA levels of CYP1A2, CYP2C9, CYP2D6, and CYP3A" /><sentence text=" However, 17OHP-C at 1 μmol/L increased CYP2C19 activity by 2" /><sentence text="8-fold (P &lt; " /><sentence text="01) and CYP2C19 expression by 2" /><sentence text="4-fold (P &lt; " /><sentence text="001), compared with vehicle-treated cells" /><sentence text=" A strong positive correlation between activity and expression of CYP2C19 was also observed (r = 0" /><sentence text="9, P &lt; " /><sentence text="001)" /><sentence text="" /><sentence text="The activity and expression of hepatic CYP2C19 was significantly increased by 17OHP-C in primary cultures of human hepatocytes" /><sentence text=" This suggests that exposure to medications that are metabolized by CYP2C19 may be decreased in pregnant patients receiving 17OHP-C"><entity charOffset="124-131" id="DDI-PubMed.24681287.s20.e0" text="17OHP-C" /></sentence><sentence text=" Metabolism of substrates of CYP1A2, CYP2C9, CYP2D6, and CYP3A are not expected to be altered in patients receiving 17OHP-C"><entity charOffset="116-123" id="DDI-PubMed.24681287.s21.e0" text="17OHP-C" /></sentence><sentence text="" /></document>